Table 3.

Physical properties of different prepared LZM‐NLCs (mean ± SD, n  = 3)

Formulations	Encapsulation efficiency%	Drug loading%	Particle size, nm	PdI	Zeta potential, mV	Release efficiency%
L10 S0.5 O10	86.97 ± 1.94	8.00 ± 0.16	389.00 ± 13.73	0.43 ± 0.04	−8.84 ± 1.64	44.22 ± 0.995
L5 S0.5 O10	93.64 ± 0.98	15.78 ± 0.13	356.93 ± 53.05	0.49 ± 0.10	−12.40 ± 0.85	64.86 ± 4.79
L5 S0.25 O10	92.64 ± 0.53	15.63 ± 0.07	289.16 ± 35.85	0.53 ± 0.02	−10.93 ± 1.95	40.68 ± 7.71
L10 S0.25 O10	95.02 ± 1.96	8.67 ± 0.16	144.33 ± 3.02	0.30 ± 0.03	−4.34 ± 0.43	57.18 ± 3.94
L10 S0.25 O30	81.80 ± 5.04	7.56 ± 0.43	71.70 ± 5.16	0.21 ± 0.02	−20.06 ± 2.70	36.50 ± 7.41
L10 S0.5 O30	89.14 ± 4.47	8.18 ± 0.37	120.20 ± 8.76	0.60 ± 0.02	−2.75 ± 1.62	38.72 ± 6.72
L5 S0.25 O30	94.72 ± 2.57	15.92 ± 0.36	155.86 ± 12.10	0.41 ± 0.01	−11.24 ± 2.14	44.88 ± 1.22
L5 S0.5 O30	95.40 ± 0.96	16.02 ± 0.13	131.93 ± 13.07	0.45 ± 0.00	−9.13 ± 1.69	45.31 ± 10.06